Document Detail

PSA supernormalisation: a surrogate of complete adenoma removal in men with benign prostatic hyperplasia.
MedLine Citation:
PMID:  21341548     Owner:  NLM     Status:  In-Process    
It is known that serum prostate-specific antigen levels (PSA) decrease gradually following surgery for benign prostatic hyperplasia (BPH), but there is not an established cut-off value for normal PSA after relief of obstruction. We evaluated the impact of prostatic adenoma enucleation on PSA levels in 110 patients who underwent transvesical suprapubic adenomectomy for symptomatic BPH. We examined PSA levels before and after open surgery and weight of the prostatic adenoma as measured by the pathologist. Forty-eight percent of the patients had a preoperative PSA level between 0 and 4, 29% between 4 and 7, and 23% between 7 and 10 ng/ml. In patients with suspected abnormality on digital rectal examination or PSA > 4.0 ng/mL systematic multisite biopsies were performed preoperatively to rule out prostate cancer. The mean weight of enucleated adenoma was 87 gr (range 50-201). The mean serum PSA decreased from 4.8 ng/ml preoperatively to 0.5 ng/ml postoperatively. The mean decrease in PSA was 90% (range 70-99%). PSA was resetted at lower level in all patients irrespectively of baseline PSA levels or BPH weight. The transvesical suprapubic adenomectomy supernormalises serum PSA lower than 1 ng/ml in 96% of patients. 100% of patients have a postoperative PSA value < 1.5 ng/ml. PSA supernormalisation represents an objective measure of complete adenoma removal. The urologists should be aware of this resetted level and they should take account of it when different ablative therapies for BPH are confronted.
Oreste Martella; Giuseppe Paradiso Galatioto; Gianna Pace; Carlo Vicentini
Related Documents :
943228 - Clear cell carcinoma of the endometrium: an analysis of 21 cases.
15213598 - Immunohistochemical staining for ki-67 and p53 helps distinguish endometrial arias-stel...
19207308 - Endometrial carcinoma detected with surepath liquid-based cervical cytology: comparison...
8687148 - Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (upsc) in re...
23360698 - Evolution of taxanes in the treatment of metastatic breast cancer.
15564178 - Recent development of sentinel lymph node biopsy for breast cancer in japan.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia     Volume:  82     ISSN:  1124-3562     ISO Abbreviation:  Arch Ital Urol Androl     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2011-02-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9308247     Medline TA:  Arch Ital Urol Androl     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  139-42     Citation Subset:  IM    
Department of Urology, Mazzini Hospital, Teramo, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series.
Next Document:  Is there a correlation between testosterone levels and the severity of the disease in male patients ...